{"organizations": [], "uuid": "995e39baead1dd2e9f5d5c351194eaaf3232f30e", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180208.html", "section_title": "Archive News &amp; Video for Thursday, 08 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-arbutus-consolidates-hbv-business/brief-arbutus-consolidates-hbv-business-around-warminster-pa-site-idUSFWN1PY12E", "country": "US", "domain_rank": 408, "title": "BRIEF-Arbutus Consolidates HBV Business Around Warminster, PA Site", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.239, "site_type": "news", "published": "2018-02-08T21:52:00.000+02:00", "replies_count": 0, "uuid": "995e39baead1dd2e9f5d5c351194eaaf3232f30e"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-arbutus-consolidates-hbv-business/brief-arbutus-consolidates-hbv-business-around-warminster-pa-site-idUSFWN1PY12E", "ord_in_thread": 0, "title": "BRIEF-Arbutus Consolidates HBV Business Around Warminster, PA Site", "locations": [], "entities": {"persons": [], "locations": [{"name": "warminster", "sentiment": "none"}, {"name": "burnaby", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "arbutus biopharma corp", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}, {"name": "biopharma corp", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 8 (Reuters) - Arbutus Biopharma Corp:\n* ARBUTUS BIOPHARMA CORP - SITE CONSOLIDATION AND ORGANIZATIONAL RESTRUCTURING TO BETTER ALIGN ITS HBV BUSINESS IN WARMINSTER, PA\n* ARBUTUS BIOPHARMA CORP - TO ACHIEVE ALIGNMENT, CO WILL REDUCE ITS GLOBAL WORKFORCE BY ABOUT 31 PERCENT AND PLANS TO CLOSE ITS BURNABY FACILITY\n* ARBUTUS BIOPHARMA CORP - WILL INCUR RESTRUCTURING COSTS RELATED TO WORKFORCE REDUCTION AND SITE CLOSURE OF ABOUT $5.0 MILLION\n* ARBUTUS BIOPHARMA CORP - ‍RESTRUCTURING COSTS WILL BE PRIMARILY PAID IN CASH IN Q2 OF 2018​ Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-08T21:52:00.000+02:00", "crawled": "2018-02-09T17:07:36.004+02:00", "highlightTitle": ""}